Sherblom James
- SEC CIK
- 0001926230
No open-market purchases or sales filed in the past year.
Current role at each company
- CMRA Comera Life Sciences Holdings, Inc.Directoras of Nov 14, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sherblom James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 (view filing)5:47 PM ET | Jan 4 | 41 days | Sherblom JamesDirector | PPurchase | +81.1K | $1.23 | +$99.7K | +21.8%452.2K after | Amended |
| Feb 14, 2023 (view filing)5:47 PM ET | Jan 4 | 41 days | Sherblom JamesDirector | PPurchase | +162.2K | $0.125 | +$20.3K | –81.1K after | AmendedDerivative |
| Sep 12, 2022 (view filing) | Sep 12 | Same day | Sherblom JamesDirector | PPurchase | +50.0K | $2.03 | +$101.5K | +15.6%371.2K after |